Arcadia Biosciences
Stock Forecast, Prediction & Price Target

Arcadia Biosciences Financial Estimates

Arcadia Biosciences Revenue Estimates

Arcadia Biosciences EBITDA Estimates

Arcadia Biosciences Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026
Revenue
 
% change YoY
$6.78M
 
N/A
$9.95M
 
46.84%
$5.33M
 
-46.46%
Avg: $6.39M
Low: $6.27M
High: $6.50M
avg. 19.88%
Avg: $7.4M
Low: $7.26M
High: $7.53M
avg. 15.80%
Net Income
 
% change YoY
$-16.13M
 
N/A
$-15.61M
 
3.23%
$-13.98M
 
10.44%
Avg: $-2.88M
Low: $-3.93M
High: $-531.88K
avg. 79.33%
Avg: $-4.42M
Low: $-3.46M
High: $-3.30M
avg. -53.16%
EBITDA
 
% change YoY
$-18.36M
 
N/A
$-22.72M
 
-23.71%
$-13.93M
 
38.65%
Avg: $-6.39M
Low: $-6.50M
High: $-6.27M
avg. 54.15%
Avg: $-7.4M
Low: $-7.53M
High: $-7.26M
avg. -15.80%
EPS
 
% change YoY
-$30.33
 
N/A
-$26.05
 
14.11%
-$11.3
 
56.62%
Avg: -$1.81
Low: -$3.18
High: -$0.43
avg. 84.02%
Avg: -$2.74
Low: -$2.8
High: -$2.67
avg. -51.80%
Operating Expenses
 
% change YoY
$26.82M
 
N/A
$19.55M
 
-27.09%
$15.96M
 
-18.35%
Avg: $27.57M
Low: $27.06M
High: $28.06M
avg. 72.66%
Avg: $31.92M
Low: $31.33M
High: $32.50M
avg. 15.80%

FAQ

What is Arcadia Biosciences stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 13.08% in 2025-2026.

We have gathered data from 1 analysts. Their low estimate is -3.93M, average is -2.88M and high is -531.88K.

What is Arcadia Biosciences stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 17.84% in 2025-2026.

We have gathered data from 1 analysts. Their low revenue estimate is $6.27M, average is $6.39M and high is $6.50M.

What is Arcadia Biosciences stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 16.11% in 2025-2026.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$3.18, average is -$1.81 and high is $-0.43.

What is the best performing analyst?

In the last twelve months analysts have been covering Arcadia Biosciences stock. The most successful analyst is Raghuram Selvaraju.